Tapewire

Nasdaq · USD

ISRG

INTUITIVE SURGICAL INC

Export transactions ↓
Tapewire entity
2878
SEC CIK
0001035267
Parsed reports
1,605

Last 12 months

Inside the activity.

0 purchase rows · 74 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025011
Dec 202507
Jan 202606
Feb 202606
Mar 202609
Apr 202602
May 202606
Jun 202607
Jul 202605
Aug 202609
Sep 202606
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 15, 2022 Filed Feb 17, 2022 02:25 UTC
Samath JamieChief Financial Officer
Tax withholdingCommon Stock 315 $289.31 $91,132.65
Disclosure

SEC source: 0001035267-22-000022 · edgardoc.xml · nonDerivative · entry 2

Samath Jamie · CIK 0001330269 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,384

F1 · kind: RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25 % of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 02:25 UTC
Samath JamieChief Financial Officer
Exercise / conversionCommon Stock 861 $0.00 $0.00
Disclosure

SEC source: 0001035267-22-000022 · edgardoc.xml · nonDerivative · entry 1

Samath Jamie · CIK 0001330269 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,699

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25 % of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 02:30 UTC
DeSantis RobertEVP & Chief Product Officer
Exercise / conversionRestricted Stock Units · Derivative 2,124 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001035267-22-000024 · edgardoc.xml · derivative · entry 6

DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,124

Underlying: Common Stock · 2,124 shares

Expires 2023-02-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Each RSU granted represents a contingent right to receive one share of Intuitive Surgical common stock. The grant vests 25% on the first anniversary of the date of grant and annually thereafter, over a four year period.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 02:30 UTC
DeSantis RobertEVP & Chief Product Officer
Exercise / conversionRestricted Stock Units · Derivative 2,874 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001035267-22-000024 · edgardoc.xml · derivative · entry 5

DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,874 shares

Expires 2022-02-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Each RSU granted represents a contingent right to receive one share of Intuitive Surgical common stock. The grant vests 25% on the first anniversary of the date of grant and annually thereafter, over a four year period.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 02:30 UTC
DeSantis RobertEVP & Chief Product Officer
Tax withholdingCommon Stock 928 $289.31 $268,479.68
Disclosure

SEC source: 0001035267-22-000024 · edgardoc.xml · nonDerivative · entry 4

DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,335

F1 · kind: RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25 % of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 02:30 UTC
DeSantis RobertEVP & Chief Product Officer
Exercise / conversionCommon Stock 2,124 $0.00 $0.00
Disclosure

SEC source: 0001035267-22-000024 · edgardoc.xml · nonDerivative · entry 3

DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,263

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25 % of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 02:30 UTC
DeSantis RobertEVP & Chief Product Officer
Tax withholdingCommon Stock 903 $289.31 $261,246.93
Disclosure

SEC source: 0001035267-22-000024 · edgardoc.xml · nonDerivative · entry 2

DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,139

F1 · kind: RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25 % of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 02:30 UTC
DeSantis RobertEVP & Chief Product Officer
Exercise / conversionCommon Stock 2,874 $0.00 $0.00
Disclosure

SEC source: 0001035267-22-000024 · edgardoc.xml · nonDerivative · entry 1

DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,042

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25 % of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 17:42 UTC
Curet MyriamEVP & Chief Medical Officer
Exercise / conversionRestricted Stock Units · Derivative 1,749 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001035267-22-000026 · edgardoc.xml · derivative · entry 7

Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,749

Underlying: Common Stock · 1,749 shares

Expires 2023-02-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Each Restricted Stock Unit, granted pursuant to the 2010 Employee Stock Option Plan, represents a contingent right to receive one share of Intuitive Surgical common stock. The grant vests 25% on the first anniversary of the date of grant and annually thereafter, over a four year period of time.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 17:42 UTC
Curet MyriamEVP & Chief Medical Officer
Exercise / conversionRestricted Stock Units · Derivative 3,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001035267-22-000026 · edgardoc.xml · derivative · entry 6

Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,000 shares

Expires 2022-02-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Each Restricted Stock Unit, granted pursuant to the 2010 Employee Stock Option Plan, represents a contingent right to receive one share of Intuitive Surgical common stock. The grant vests 25% on the first anniversary of the date of grant and annually thereafter, over a four year period of time.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 17:42 UTC
Curet MyriamEVP & Chief Medical Officer
Tax withholdingCommon Stock 868 $289.31 $251,121.08
Disclosure

SEC source: 0001035267-22-000026 · edgardoc.xml · nonDerivative · entry 4

Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,839

F1 · kind: RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25 % of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 17:42 UTC
Curet MyriamEVP & Chief Medical Officer
Exercise / conversionCommon Stock 1,749 $0.00 $0.00
Disclosure

SEC source: 0001035267-22-000026 · edgardoc.xml · nonDerivative · entry 3

Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,707

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25 % of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 17:42 UTC
Curet MyriamEVP & Chief Medical Officer
Tax withholdingCommon Stock 1,403 $289.31 $405,901.93
Disclosure

SEC source: 0001035267-22-000026 · edgardoc.xml · nonDerivative · entry 2

Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,958

F1 · kind: RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25 % of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 17:42 UTC
Curet MyriamEVP & Chief Medical Officer
Exercise / conversionCommon Stock 3,000 $0.00 $0.00
Disclosure

SEC source: 0001035267-22-000026 · edgardoc.xml · nonDerivative · entry 1

Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,361

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25 % of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 19:43 UTC
Widman FredrikVP Corporate Controller
Exercise / conversionRestricted Stock Units · Derivative 393 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001035267-22-000028 · edgardoc.xml · derivative · entry 6

Widman Fredrik · CIK 0001897970 · VP Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 393

Underlying: Common Stock · 393 shares

Expires 2029-02-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Each RSU granted represents a contingent right to receive one share of Intuitive Surgical common stock. The grant vests 25% on the first anniversary of the date of grant and annually thereafter, over a four year period.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 19:43 UTC
Widman FredrikVP Corporate Controller
Exercise / conversionRestricted Stock Units · Derivative 486 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001035267-22-000028 · edgardoc.xml · derivative · entry 5

Widman Fredrik · CIK 0001897970 · VP Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 486 shares

Expires 2028-02-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Each RSU granted represents a contingent right to receive one share of Intuitive Surgical common stock. The grant vests 25% on the first anniversary of the date of grant and annually thereafter, over a four year period.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 19:43 UTC
Widman FredrikVP Corporate Controller
Tax withholdingCommon Stock 136 $289.31 $39,346.16
Disclosure

SEC source: 0001035267-22-000028 · edgardoc.xml · nonDerivative · entry 4

Widman Fredrik · CIK 0001897970 · VP Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,731

F1 · kind: RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25 % of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 19:43 UTC
Widman FredrikVP Corporate Controller
Exercise / conversionCommon Stock 393 $0.00 $0.00
Disclosure

SEC source: 0001035267-22-000028 · edgardoc.xml · nonDerivative · entry 3

Widman Fredrik · CIK 0001897970 · VP Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,867

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25 % of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 19:43 UTC
Widman FredrikVP Corporate Controller
Tax withholdingCommon Stock 192 $289.31 $55,547.52
Disclosure

SEC source: 0001035267-22-000028 · edgardoc.xml · nonDerivative · entry 2

Widman Fredrik · CIK 0001897970 · VP Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,474

F1 · kind: RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25 % of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 19:43 UTC
Widman FredrikVP Corporate Controller
Exercise / conversionCommon Stock 486 $0.00 $0.00
Disclosure

SEC source: 0001035267-22-000028 · edgardoc.xml · nonDerivative · entry 1

Widman Fredrik · CIK 0001897970 · VP Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,666

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25 % of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 23:25 UTC
Charlton Henry LSenior Vice President & Chief
Exercise / conversionRestricted Stock Units · Derivative 1,311 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001035267-22-000030 · edgardoc.xml · derivative · entry 6

Charlton Henry L · CIK 0001897642 · Senior Vice President & Chief

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,311

Underlying: Common Stock · 1,311 shares

Expires 2029-02-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Each RSU granted represents a contingent right to receive one share of Intuitive Surgical common stock. The grant vests 25% on the first anniversary of the date of grant and annually thereafter, over a four year period.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 23:25 UTC
Charlton Henry LSenior Vice President & Chief
Exercise / conversionRestricted Stock Units · Derivative 1,875 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001035267-22-000030 · edgardoc.xml · derivative · entry 5

Charlton Henry L · CIK 0001897642 · Senior Vice President & Chief

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,875 shares

Expires 2028-02-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Each RSU granted represents a contingent right to receive one share of Intuitive Surgical common stock. The grant vests 25% on the first anniversary of the date of grant and annually thereafter, over a four year period.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 23:25 UTC
Charlton Henry LSenior Vice President & Chief
Tax withholdingCommon Stock 395 $289.31 $114,277.45
Disclosure

SEC source: 0001035267-22-000030 · edgardoc.xml · nonDerivative · entry 4

Charlton Henry L · CIK 0001897642 · Senior Vice President & Chief

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,655

F1 · kind: RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25 % of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account.

F2 · balance_after: Includes 321 shares that should have been included on Form 3 filed Jan 7, 2022.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 23:25 UTC
Charlton Henry LSenior Vice President & Chief
Exercise / conversionCommon Stock 1,311 $0.00 $0.00
Disclosure

SEC source: 0001035267-22-000030 · edgardoc.xml · nonDerivative · entry 3

Charlton Henry L · CIK 0001897642 · Senior Vice President & Chief

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,050

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25 % of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account.

F2 · balance_after: Includes 321 shares that should have been included on Form 3 filed Jan 7, 2022.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 23:25 UTC
Charlton Henry LSenior Vice President & Chief
Tax withholdingCommon Stock 577 $289.31 $166,931.87
Disclosure

SEC source: 0001035267-22-000030 · edgardoc.xml · nonDerivative · entry 2

Charlton Henry L · CIK 0001897642 · Senior Vice President & Chief

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,739

F1 · kind: RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25 % of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account.

F2 · balance_after: Includes 321 shares that should have been included on Form 3 filed Jan 7, 2022.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 23:25 UTC
Charlton Henry LSenior Vice President & Chief
Exercise / conversionCommon Stock 1,875 $0.00 $0.00
Disclosure

SEC source: 0001035267-22-000030 · edgardoc.xml · nonDerivative · entry 1

Charlton Henry L · CIK 0001897642 · Senior Vice President & Chief

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,316

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25 % of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account.

F2 · balance_after: Includes 321 shares that should have been included on Form 3 filed Jan 7, 2022.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 21:58 UTC
GUTHART GARY SDirector · President & CEO
Exercise / conversionRestricted Stock Units · Derivative 3,750 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001567619-22-004902 · doc1.xml · derivative · entry 9

GUTHART GARY S · CIK 0001280628 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,750

Underlying: Common Stock · 3,750 shares

Expires 2023-02-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Each Restricted Stock Unit, granted pursuant to the 2010 Employee Stock Option Plan, represents a contingent right to receive one share of Intuitive Surgical common stock. The grant vests 25% on the first anniversary of the date of grant and annually thereafter, over a four year period of time.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 21:58 UTC
GUTHART GARY SDirector · President & CEO
Exercise / conversionRestricted Stock Units · Derivative 4,248 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001567619-22-004902 · doc1.xml · derivative · entry 8

GUTHART GARY S · CIK 0001280628 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,248 shares

Expires 2022-02-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Each Restricted Stock Unit, granted pursuant to the 2010 Employee Stock Option Plan, represents a contingent right to receive one share of Intuitive Surgical common stock. The grant vests 25% on the first anniversary of the date of grant and annually thereafter, over a four year period of time.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 21:58 UTC
GUTHART GARY SDirector · President & CEO
Tax withholdingCommon Stock 1,860 $289.31 $538,116.60
Disclosure

SEC source: 0001567619-22-004902 · doc1.xml · nonDerivative · entry 4

GUTHART GARY S · CIK 0001280628 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,543

F1 · kind: RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25 % of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account.

F2 · balance_after: On October 5, 2021, the common stock and equity grants of Intuitive Surgical split 3-for-1, resulting in the reporting person's ownership of the company's stock and equity grants to increase (for every one share owned or granted, 2 additional shares were issued) and the exercise price of stock option grants to decrease to 1/3rd of the original grant price.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 21:58 UTC
GUTHART GARY SDirector · President & CEO
Exercise / conversionCommon Stock 3,750 $0.00 $0.00
Disclosure

SEC source: 0001567619-22-004902 · doc1.xml · nonDerivative · entry 3

GUTHART GARY S · CIK 0001280628 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,403

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25 % of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account.

F2 · balance_after: On October 5, 2021, the common stock and equity grants of Intuitive Surgical split 3-for-1, resulting in the reporting person's ownership of the company's stock and equity grants to increase (for every one share owned or granted, 2 additional shares were issued) and the exercise price of stock option grants to decrease to 1/3rd of the original grant price.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 21:58 UTC
GUTHART GARY SDirector · President & CEO
Tax withholdingCommon Stock 1,595 $289.31 $461,449.45
Disclosure

SEC source: 0001567619-22-004902 · doc1.xml · nonDerivative · entry 2

GUTHART GARY S · CIK 0001280628 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,653

F1 · kind: RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25 % of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account.

F2 · balance_after: On October 5, 2021, the common stock and equity grants of Intuitive Surgical split 3-for-1, resulting in the reporting person's ownership of the company's stock and equity grants to increase (for every one share owned or granted, 2 additional shares were issued) and the exercise price of stock option grants to decrease to 1/3rd of the original grant price.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 21:58 UTC
GUTHART GARY SDirector · President & CEO
Exercise / conversionCommon Stock 4,248 $0.00 $0.00
Disclosure

SEC source: 0001567619-22-004902 · doc1.xml · nonDerivative · entry 1

GUTHART GARY S · CIK 0001280628 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,248

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25 % of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account.

F2 · balance_after: On October 5, 2021, the common stock and equity grants of Intuitive Surgical split 3-for-1, resulting in the reporting person's ownership of the company's stock and equity grants to increase (for every one share owned or granted, 2 additional shares were issued) and the exercise price of stock option grants to decrease to 1/3rd of the original grant price.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 21:59 UTC
MOHR MARSHALLsee Remarks
Exercise / conversionRestricted Stock Units · Derivative 1,749 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001567619-22-004904 · doc1.xml · derivative · entry 7

MOHR MARSHALL · CIK 0001252986 · see Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,749

Underlying: Common Stock · 1,749 shares

Expires 2023-02-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Each Restricted Stock Unit, granted pursuant to the 2010 Employee Stock Option Plan, represents a contingent right to receive one share of Intuitive Surgical common stock. The grant vests 25% on the first anniversary of the date of grant and annually thereafter, over a four year period of time.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 21:59 UTC
MOHR MARSHALLsee Remarks
Exercise / conversionRestricted Stock Units · Derivative 2,124 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001567619-22-004904 · doc1.xml · derivative · entry 6

MOHR MARSHALL · CIK 0001252986 · see Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,124 shares

Expires 2022-02-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Each Restricted Stock Unit, granted pursuant to the 2010 Employee Stock Option Plan, represents a contingent right to receive one share of Intuitive Surgical common stock. The grant vests 25% on the first anniversary of the date of grant and annually thereafter, over a four year period of time.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 21:59 UTC
MOHR MARSHALLsee Remarks
Tax withholdingCommon Stock 668 $289.31 $193,259.08
Disclosure

SEC source: 0001567619-22-004904 · doc1.xml · nonDerivative · entry 4

MOHR MARSHALL · CIK 0001252986 · see Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,532

F1 · kind: RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25 % of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 21:59 UTC
MOHR MARSHALLsee Remarks
Exercise / conversionCommon Stock 1,749 $0.00 $0.00
Disclosure

SEC source: 0001567619-22-004904 · doc1.xml · nonDerivative · entry 3

MOHR MARSHALL · CIK 0001252986 · see Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,200

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25 % of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 21:59 UTC
MOHR MARSHALLsee Remarks
Tax withholdingCommon Stock 749 $289.31 $216,693.19
Disclosure

SEC source: 0001567619-22-004904 · doc1.xml · nonDerivative · entry 2

MOHR MARSHALL · CIK 0001252986 · see Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,451

F1 · kind: RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25 % of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 21:59 UTC
MOHR MARSHALLsee Remarks
Exercise / conversionCommon Stock 2,124 $0.00 $0.00
Disclosure

SEC source: 0001567619-22-004904 · doc1.xml · nonDerivative · entry 1

MOHR MARSHALL · CIK 0001252986 · see Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,200

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25 % of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account.

Read SEC document
January 25, 2022 Filed Jan 26, 2022 17:00 UTC
DeSantis RobertEVP & Chief Product Officer
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 597 $0.00 Strike: $245.60 $0.00
Disclosure

SEC source: 0001035267-22-000008 · edgardoc.xml · derivative · entry 12

DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,272

Underlying: Common Stock · 597 shares

Expires 2031-02-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2022.

F2 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.

Read SEC document
January 25, 2022 Filed Jan 26, 2022 17:00 UTC
DeSantis RobertEVP & Chief Product Officer
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 273 $0.00 Strike: $242.34 $0.00
Disclosure

SEC source: 0001035267-22-000008 · edgardoc.xml · derivative · entry 11

DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,352

Underlying: Common Stock · 273 shares

Expires 2030-08-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2022.

F4 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.

Read SEC document
January 25, 2022 Filed Jan 26, 2022 17:00 UTC
DeSantis RobertEVP & Chief Product Officer
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 270 $0.00 Strike: $179.70 $0.00
Disclosure

SEC source: 0001035267-22-000008 · edgardoc.xml · derivative · entry 10

DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,808

Underlying: Common Stock · 270 shares

Expires 2030-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2022.

F3 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The grant vests 25% on the first anniversary of the date of grant and monthly thereafter, over a four year period of time.

Read SEC document
January 25, 2022 Filed Jan 26, 2022 17:00 UTC
DeSantis RobertEVP & Chief Product Officer
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 270 $0.00 Strike: $177.99 $0.00
Disclosure

SEC source: 0001035267-22-000008 · edgardoc.xml · derivative · entry 9

DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,358

Underlying: Common Stock · 270 shares

Expires 2030-02-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2022.

F2 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.

Read SEC document
January 25, 2022 Filed Jan 26, 2022 17:00 UTC
DeSantis RobertEVP & Chief Product Officer
SaleCommon Stock 270 $261.64 $70,642.80
Disclosure

SEC source: 0001035267-22-000008 · edgardoc.xml · nonDerivative · entry 8

DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,092

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2022.

Read SEC document
January 25, 2022 Filed Jan 26, 2022 17:00 UTC
DeSantis RobertEVP & Chief Product Officer
Exercise / conversionCommon Stock 270 $177.99 $48,056.41
Disclosure

SEC source: 0001035267-22-000008 · edgardoc.xml · nonDerivative · entry 7

DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,362

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2022.

Read SEC document
January 25, 2022 Filed Jan 26, 2022 17:00 UTC
DeSantis RobertEVP & Chief Product Officer
SaleCommon Stock 270 $261.64 $70,642.80
Disclosure

SEC source: 0001035267-22-000008 · edgardoc.xml · nonDerivative · entry 6

DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,092

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2022.

Read SEC document
January 25, 2022 Filed Jan 26, 2022 17:00 UTC
DeSantis RobertEVP & Chief Product Officer
Exercise / conversionCommon Stock 270 $179.70 $48,519.00
Disclosure

SEC source: 0001035267-22-000008 · edgardoc.xml · nonDerivative · entry 5

DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,362

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2022.

Read SEC document
January 25, 2022 Filed Jan 26, 2022 17:00 UTC
DeSantis RobertEVP & Chief Product Officer
SaleCommon Stock 273 $261.64 $71,427.72
Disclosure

SEC source: 0001035267-22-000008 · edgardoc.xml · nonDerivative · entry 4

DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,092

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2022.

Read SEC document
January 25, 2022 Filed Jan 26, 2022 17:00 UTC
DeSantis RobertEVP & Chief Product Officer
Exercise / conversionCommon Stock 273 $242.34 $66,157.92
Disclosure

SEC source: 0001035267-22-000008 · edgardoc.xml · nonDerivative · entry 3

DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,365

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2022.

Read SEC document
January 25, 2022 Filed Jan 26, 2022 17:00 UTC
DeSantis RobertEVP & Chief Product Officer
SaleCommon Stock 597 $261.64 $156,199.08
Disclosure

SEC source: 0001035267-22-000008 · edgardoc.xml · nonDerivative · entry 2

DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,092

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2022.

Read SEC document
January 25, 2022 Filed Jan 26, 2022 17:00 UTC
DeSantis RobertEVP & Chief Product Officer
Exercise / conversionCommon Stock 597 $245.60 $146,623.20
Disclosure

SEC source: 0001035267-22-000008 · edgardoc.xml · nonDerivative · entry 1

DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,689

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2022.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.